A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19
Main Authors: | Philip Keith, Matthew Day, Linda Perkins, Lou Moyer, Kristi Hewitt, Adam Wells |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-04-01
|
Series: | Critical Care |
Online Access: | http://link.springer.com/article/10.1186/s13054-020-2836-4 |
Similar Items
-
The successful use of therapeutic plasma exchange for severe COVID-19 acute respiratory distress syndrome with multiple organ failure
by: Philip Keith, et al.
Published: (2020-06-01) -
Novel Avian Coronavirus and Fulminating Disease in Guinea Fowl, France
by: Etienne Liais, et al.
Published: (2014-01-01) -
Experience of Treatments of Amanita Phalloides-induced Fulminant Liver Failure with Molecular Adsorbent Recirculating System and Therapeutic Plasma Exchange
by: Chunting Wang, et al.
Published: (2014-12-01) -
The therapeutic efficacy of adjunct therapeutic plasma exchange for septic shock with multiple organ failure: a single-center experience
by: Philip D. Keith, et al.
Published: (2020-08-01) -
Reverse takotsubo cardiomyopathy in fulminant COVID-19 associated with cytokine release syndrome and resolution following therapeutic plasma exchange: a case-report
by: Fahad Faqihi, et al.
Published: (2020-08-01)